Novo Nordisk As Stock Price History

NVO Stock  USD 106.80  0.67  0.63%   
Below is the normalized historical share price chart for Novo Nordisk AS extending back to April 30, 1981. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novo Nordisk stands at 106.80, as last reported on the 30th of November, with the highest price reaching 107.40 and the lowest price hitting 105.35 during the day.
IPO Date
4th of January 1982
200 Day MA
128.1924
50 Day MA
118.5756
Beta
0.165
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. Novo Nordisk AS has Sharpe Ratio of -0.2, which conveys that the firm had a -0.2% return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Standard Deviation of 1.81, mean deviation of 1.38, and Risk Adjusted Performance of (0.13) to check out the risk estimate we provide.
  
At this time, Novo Nordisk's Total Stockholder Equity is very stable compared to the past year. As of the 30th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 330.2 B, while Common Stock Shares Outstanding is likely to drop about 3.7 B. . At this time, Novo Nordisk's Price Cash Flow Ratio is very stable compared to the past year. As of the 30th of November 2024, Price Sales Ratio is likely to grow to 14.15, though Price Earnings To Growth Ratio is likely to grow to (1.49). Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.205

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNVO

Estimated Market Risk

 1.8
  actual daily
16
84% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.
Price Book
27.8164
Enterprise Value Ebitda
24.0992
Price Sales
1.7168
Shares Float
3.2 B
Dividend Share
9.9

Novo Nordisk Stock Price History Chart

There are several ways to analyze Novo Stock price data. The simplest method is using a basic Novo candlestick price chart, which shows Novo Nordisk price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 13, 2024137.0
Lowest PriceNovember 18, 202499.81

Novo Nordisk November 30, 2024 Stock Price Synopsis

Various analyses of Novo Nordisk's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novo Stock. It can be used to describe the percentage change in the price of Novo Nordisk from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novo Stock.
Novo Nordisk Price Rate Of Daily Change 1.01 
Novo Nordisk Price Action Indicator 0.76 
Novo Nordisk Price Daily Balance Of Power 0.33 
Novo Nordisk Accumulation Distribution 42,283 

Novo Nordisk November 30, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Novo Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Novo Nordisk intraday prices and daily technical indicators to check the level of noise trading in Novo Stock and then apply it to test your longer-term investment strategies against Novo.

Novo Stock Price History Data

The price series of Novo Nordisk for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 39.35 with a coefficient of variation of 9.34. The daily prices for the period are spread out with arithmetic mean of 118.36. The median price for the last 90 days is 117.33. The company underwent 2:1 stock split on 20th of September 2023. Novo Nordisk AS issued dividends to stockholders on 2024-08-16.
OpenHighLowCloseVolume
11/29/2024 105.43  107.40  105.35  106.80  2,215,240 
11/27/2024 105.79  106.13  104.96  106.13  3,990,600 
11/26/2024 106.67  107.70  105.63  106.13  6,726,700 
11/25/2024 105.31  105.92  104.00  104.56  4,057,615 
11/22/2024 103.91  106.23  103.86  105.06  5,405,162 
11/21/2024 103.18  103.22  101.51  102.63  5,852,239 
11/20/2024 103.43  105.74  103.00  105.27  7,509,744 
11/19/2024 101.18  103.12  101.14  102.63  5,073,369 
11/18/2024 100.32  100.67  99.42  99.81  8,584,015 
11/15/2024 101.67  102.34  100.32  101.74  7,790,327 
11/14/2024 106.83  107.00  105.13  105.32  4,416,329 
11/13/2024 106.88  107.79  106.55  106.91  3,086,355 
11/12/2024 106.81  107.61  105.70  107.06  4,838,098 
11/11/2024 109.67  110.61  108.93  109.09  4,701,422 
11/08/2024 107.15  107.87  106.43  107.20  5,217,319 
11/07/2024 106.10  107.73  105.59  107.63  8,313,394 
11/06/2024 108.27  108.74  105.03  105.36  11,581,409 
11/05/2024 107.98  110.30  107.75  110.13  6,436,225 
11/04/2024 110.19  110.66  109.44  109.72  6,173,354 
11/01/2024 112.88  113.02  111.79  111.94  4,450,401 
10/31/2024 110.21  112.16  109.63  111.95  8,332,210 
10/30/2024 108.89  113.76  107.27  113.24  11,048,070 
10/29/2024 111.62  113.27  111.15  111.98  8,118,161 
10/28/2024 112.41  112.72  111.67  112.36  5,165,797 
10/25/2024 113.90  114.19  113.10  113.38  4,195,144 
10/24/2024 115.21  115.26  113.92  113.92  4,040,512 
10/23/2024 116.33  116.43  114.95  115.74  3,217,815 
10/22/2024 115.00  116.65  114.76  116.47  4,685,876 
10/21/2024 117.95  117.96  116.88  117.33  3,230,385 
10/18/2024 117.76  118.27  117.15  118.09  2,908,548 
10/17/2024 118.59  119.07  118.12  118.22  2,855,611 
10/16/2024 116.95  118.06  116.44  118.03  3,016,791 
10/15/2024 118.99  119.09  117.14  117.81  3,599,176 
10/14/2024 119.60  120.47  119.55  119.78  2,473,404 
10/11/2024 119.92  120.56  119.48  120.04  3,911,172 
10/10/2024 117.98  118.44  117.12  117.53  2,909,954 
10/09/2024 116.54  117.16  115.82  117.00  3,780,949 
10/08/2024 117.44  117.89  116.59  117.20  3,643,073 
10/07/2024 117.14  118.55  117.08  117.77  4,241,948 
10/04/2024 114.24  115.16  113.79  115.12  6,177,024 
10/03/2024 116.24  116.33  115.03  115.08  4,312,627 
10/02/2024 116.68  116.79  115.40  116.48  5,905,151 
10/01/2024 118.79  118.92  117.32  118.01  3,555,454 
09/30/2024 117.59  119.12  117.49  119.07  6,472,823 
09/27/2024 120.55  121.34  119.15  120.76  9,475,677 
09/26/2024 125.60  125.60  123.98  124.30  4,366,183 
09/25/2024 127.37  127.61  126.41  126.95  2,934,434 
09/24/2024 124.32  126.66  123.77  125.44  4,787,409 
09/23/2024 124.00  125.27  122.94  123.70  6,519,081 
09/20/2024 129.10  129.48  126.13  127.51  9,241,631 
09/19/2024 134.66  135.18  133.63  134.88  2,548,708 
09/18/2024 132.83  133.27  131.30  132.06  2,778,137 
09/17/2024 133.60  135.16  131.80  132.00  3,316,166 
09/16/2024 138.06  138.22  136.77  136.90  1,639,188 
09/13/2024 136.86  137.89  136.37  137.00  2,309,135 
09/12/2024 135.24  136.97  134.66  136.66  2,003,103 
09/11/2024 133.14  135.82  130.98  135.23  3,888,212 
09/10/2024 129.23  130.12  128.42  129.78  2,140,370 
09/09/2024 132.03  132.94  130.91  131.91  1,766,414 
09/06/2024 133.76  134.15  130.57  131.14  2,589,793 
09/05/2024 132.01  132.66  130.53  130.89  2,631,525 

About Novo Nordisk Stock history

Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.5 B3.7 B
Net Income Applicable To Common Shares63.9 B67 B

Novo Nordisk Stock Technical Analysis

Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novo Nordisk technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novo Nordisk trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Novo Nordisk Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.224
Dividend Share
9.9
Earnings Share
2.99
Revenue Per Share
60.698
Quarterly Revenue Growth
0.214
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.